APA (7th ed.) Citation

P, S., Y, X., Y, D., Y, F., H, Z., & X, L. Circulating Interleukin-22 Is a Biomarker for Newly Diagnosed Type 2 Diabetes Mellitus and Associated with Hypoglycemic Effect of Sitagliptin. Dove Medical Press.

Chicago Style (17th ed.) Citation

P, Sun, Xiao Y, Dong Y, Feng Y, Zheng H, and Liao X. Circulating Interleukin-22 Is a Biomarker for Newly Diagnosed Type 2 Diabetes Mellitus and Associated with Hypoglycemic Effect of Sitagliptin. Dove Medical Press.

MLA (9th ed.) Citation

P, Sun, et al. Circulating Interleukin-22 Is a Biomarker for Newly Diagnosed Type 2 Diabetes Mellitus and Associated with Hypoglycemic Effect of Sitagliptin. Dove Medical Press.